Hospital
North Shore Medical Center, INC.
North Shore Medical Center, INC. was paid $9.85M by Medicaid between Jan 2018 and Dec 2024, across 142 billing codes. Its largest line is 90834, psychotherapy session, about 45 minutes — 40% of everything it billed.
33Billing provider infoNORTH SHORE MEDICAL CENTER, INC.
SALEM, MA 01970
SALEM, MA 01970
33aNPI1417972647assigned 07/12/2006
33bProvider typePsychiatric Hospital Unit
28Total paid$9.85M
24GClaims127,827
24DCodes billed142
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Psychiatric Hospital Unit providers in Massachusetts
Rank by total paid#4 of 27
Median peer was paid$138K
This provider vs. median72×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 22,353 | $1.02M | |
| 2019 | 41,331 | $2.12M | |
| 2020 | 21,623 | $1.70M | |
| 2021 | 15,663 | $1.43M | |
| 2022 | 15,387 | $1.59M | |
| 2023 | 7,992 | $1.08M | |
| 2024incomplete | 3,478 | $903K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 40% | 46,337 | 21,551 | $3.90M |
| S9485 | Crisis intervention mental health services, per diem | 6.9% | 984 | 764 | $680K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 5.6% | 5,864 | 5,712 | $556K |
| 96133 | 5.3% | 1,133 | 1,131 | $522K | |
| 90791 | Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation | 5.2% | 3,688 | 3,568 | $512K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 4.4% | 2,676 | 2,553 | $433K |
| 96137 | 4.4% | 1,085 | 1,077 | $431K | |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 3.3% | 2,128 | 2,057 | $328K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3.2% | 5,215 | 5,057 | $318K |
| 96118 | 2.5% | 254 | 254 | $244K | |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.9% | 439 | 415 | $186K |
| 90847 | Family psychotherapy with the patient present, 50 minutes | 1.9% | 2,085 | 1,283 | $183K |
130 more codes
| 90837 | Psychotherapy session, about an hour | 1.8% | 1,768 | $182K |
| 90792 | Psychiatric diagnostic evaluation with medical services | 1.8% | 1,636 | $176K |
| 99285 | Emergency room visit (most serious) | 1.8% | 1,034 | $174K |
| 90846 | Family psychotherapy without the patient present, 50 minutes | 1.2% | 1,277 | $123K |
| 96132 | 1.2% | 1,145 | $122K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 708 | $90K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 1,728 | $73K |
| 96136 | <1% | 1,086 | $53K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 241 | $40K |
| 90887 | <1% | 946 | $39K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 306 | $39K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 1,013 | $34K |
| 99402 | <1% | 409 | $33K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 159 | $33K |
| 96139 | <1% | 99 | $28K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 587 | $27K |
| 87631 | <1% | 245 | $27K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 965 | $22K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 109 | $15K |
| 90882 | <1% | 335 | $14K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,356 | $14K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 234 | $13K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 87 | $11K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,218 | $10K |
| 86140 | <1% | 495 | $9K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,766 | $9K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,513 | $8K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 185 | $8K |
| 86480 | <1% | 134 | $8K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,157 | $7K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 566 | $6K |
| 80053 | Comprehensive metabolic panel | <1% | 1,648 | $6K |
| 86618 | <1% | 83 | $5K | |
| G0378 | Hospital observation service, per hour | <1% | 192 | $5K |
| 87070 | <1% | 588 | $5K | |
| 83516 | <1% | 149 | $4K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,161 | $4K |
| 82728 | <1% | 382 | $4K | |
| 84439 | <1% | 636 | $4K | |
| 96138 | <1% | 125 | $4K | |
| 80076 | <1% | 1,055 | $4K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 27 | $3K |
| 87077 | <1% | 654 | $3K | |
| 86664 | <1% | 60 | $3K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 498 | $3K |
| 87186 | <1% | 742 | $3K | |
| 86665 | <1% | 60 | $3K | |
| 80061 | Lipid panel | <1% | 1,431 | $2K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 16 | $2K |
| 81025 | <1% | 332 | $2K | |
| 83690 | <1% | 325 | $2K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 152 | $2K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 66 | $2K |
| J3490 | Unclassified drugs | <1% | 45 | $2K |
| 84484 | <1% | 190 | $2K | |
| 83550 | <1% | 233 | $2K | |
| 82784 | <1% | 139 | $2K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 42 | $2K |
| 83655 | <1% | 106 | $1K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 561 | $1K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 27 | $1K |
| 77080 | <1% | 189 | $1K | |
| 83540 | <1% | 277 | $1K | |
| 83735 | <1% | 703 | $1K | |
| 80050 | General health panel | <1% | 74 | $1K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 41 | $1K |
| 83880 | <1% | 114 | $1K | |
| 85652 | <1% | 428 | $1K | |
| 81001 | <1% | 855 | $901.65 | |
| 82150 | <1% | 57 | $830.34 | |
| 86803 | <1% | 44 | $801.74 | |
| 82607 | <1% | 379 | $768.26 | |
| 85027 | <1% | 1,101 | $754.01 | |
| 87040 | <1% | 60 | $719.41 | |
| 86003 | <1% | 14 | $713.50 | |
| 81002 | <1% | 256 | $657.68 | |
| 86039 | <1% | 13 | $617.88 | |
| 84153 | <1% | 308 | $616.48 | |
| 87205 | <1% | 179 | $576.83 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 154 | $549.30 |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 751 | $532.68 |
| 71045 | Radiologic examination, chest; single view | <1% | 135 | $448.99 |
| 82248 | <1% | 52 | $439.01 | |
| 84460 | <1% | 102 | $423.72 | |
| 84702 | <1% | 25 | $375.07 | |
| 83970 | <1% | 107 | $371.55 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,814 | $371.46 |
| 85610 | <1% | 1,686 | $331.75 | |
| 82043 | <1% | 528 | $320.54 | |
| 84450 | <1% | 66 | $287.60 | |
| 84436 | <1% | 31 | $286.08 | |
| 87046 | <1% | 32 | $240.80 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 158 | $236.68 |
| 73610 | <1% | 48 | $226.83 | |
| 87045 | <1% | 31 | $223.08 | |
| 81003 | <1% | 172 | $214.99 | |
| 84100 | <1% | 145 | $162.50 | |
| 86900 | <1% | 13 | $156.43 | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 27 | $140.49 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 12 | $134.53 |
| 86038 | <1% | 18 | $132.24 | |
| 83605 | <1% | 13 | $126.75 | |
| 86780 | <1% | 13 | $120.70 | |
| 87081 | <1% | 25 | $119.02 | |
| 82565 | <1% | 67 | $105.99 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 184 | $105.00 |
| 84703 | <1% | 13 | $89.18 | |
| 85045 | <1% | 31 | $88.16 | |
| 73630 | <1% | 24 | $75.61 | |
| 86850 | <1% | 12 | $64.98 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 28 | $57.70 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 237 | $45.94 |
| 87076 | <1% | 72 | $34.80 | |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | <1% | 350 | $29.40 |
| 86901 | <1% | 13 | $27.30 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 187 | $0.00 |
| 73130 | 0% | 14 | $0.00 | |
| 82948 | 0% | 16 | $0.00 | |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 116 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 206 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 52 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 36 | $0.00 |
| 82962 | 0% | 297 | $0.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 166 | $0.00 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 99 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 108 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 16 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 87 | $0.00 |
| 82746 | 0% | 13 | $0.00 | |
| 80069 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialADAMS, CHARLES (CFO)
| Provider | Location | Paid |
|---|---|---|
| North Shore Medical Center, INC. | Salem, MA | $137.69M |
| Charles S Adams Od Apc | Bossier City, LA | $18K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.